Abstract
Urinary output of an endogenous monoamine oxidase inhibitor and benzodiazepine receptor binding inhibitor (tribulin) was raised in a group of patients with generalised anxiety disorder compared with controls. Tribulin levels remained relatively constant in individual patients over the 6-week period of observation, mean values remaining high even after reduction of anxiety following non-drug behaviour therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Armando I, Glover V, Sandler M (1986) Distribution of endogenous benzodiazepine receptor ligand-monoamine oxidase inhibitory activity (tribulin) in tissues. Life Sci 38:2063–2067
Ballenger JC, Post RM, Jimerson DC, Lake R, Zuckerman M (1984) Neurobiological correlates of depression and anxiety in normal individuals. In: Post RM, Ballenger JC (eds) Frontiers of clinical neuroscience, vol I. Neurobiology of mood disorders. Williams and Wilkins, Baltimore, pp 481–501
Bhattacharya SK, Glover V, Sandler M, Clow A, Topham A, Bernadt M, Murray R (1982) Raised endogenous monoamine oxidase inhibitor output in post-withdrawal alcoholics: effects of L-dopa and ethanol. Biol Psychiatry 17:829–836
Braestrup C, Nielson M (1982) Neurotransmitters and CNS disease. Anxiety. Lancet II:1030–1034
Charney DS, Redmond DE (1983) Neuro-biological mechanism in human anxiety. Evidence supporting central noradrenergic hyperactivity. Neuropharmacology 22:1531–1536
Clow A, Glover V, Armando I, Sandler M (1983) New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor? Life Sci 33:735–741
Clow A, Glover V, Weg MW, Walker PL, Sheehan DV, Carr DB, Sandler M (1988) Urinary catecholamine metabolite and tribulin output during lactate infusion. Br J Psychiatry 152:122–126
Dorow R, Horowski R, Paschelke G, Amin M (1983) Severe anxiety induced by FG 7142, a β-carboline ligand for benzodiazepine receptors. Lancet II:98–99
Elsworth JD, Dewar D, Glover V, Goodwin BL, Clow A, Sandler M (1986) Purification and characterization of tribulin, an endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding. J Neural Transm 67:45–56
Fell D, Derbyshire DR, Maile CJD, Larsson I-M, Ellis R, Achole KJ, Smith G (1985) Measurement of plasma catecholamine concentrations. An assessment of anxiety. Br J Anaesth 57:770–774
Glover V, Reveley MA, Sandler M (1980) Monoamine oxidase inhibitor in human urine. Biochem Pharmacol 29:467–470
Glover V, Bhattacharya SK, Sandler M, File SE (1981) Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor. Nature 292:347–349
Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychiatry: 50–55
Insel TR, Ninan PT, Aloi J, Jimerson DC, Skolnick P, Paul SM (1984) A benzodiazepine receptor-mediated model of anxiety. Arch Gen Psychiatry 41:741–750
Jaffé (1886) Über den Niederschlag, welchen Pikrinsäure in normalen Harn erzeugt und über eine neue Reaktion des Creatinins. Z Physiol Chem 10:391–400
Malick JB, Enna SJ, Yamamura HI (1983) Anxiolytics: neurochemical, behavioral and clinical perspectives. Raven Press, New York
Petursson H, Reveley MA, Glover V, Sandler M (1981) Urinary MAO inhibitor in psychiatric illness. Psychiatr Res. 5:335–340
Petursson H, Bhattacharya SK, Glover V, Sandler M, Lader MH (1982) Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. Br J Psychiatry 140:7–10
Post RM, Lake CR, Jimerson DC, Bunney WE, Wood JH, Ziegler MG, Goodwin FK (1978) Cerebrospinal fluid norepinephrine in affective illness. Am J Psychiatry 135:907–912
Sandler M (1982) The emergence of tribulin. TIPS 3:471–472
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clow, A., Glover, V., Sandler, M. et al. Increased urinary tribulin output in generalised anxiety disorder. Psychopharmacology 95, 378–380 (1988). https://doi.org/10.1007/BF00181951
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00181951